Accelerate biotechnology

Batavia Biosciences nominated for prestigious European Business Award – Innovation

Leiden, February 1, 2018 Today, Batavia Biosciences announces to be selected as Ones to Watch for the Netherlands in the prestigious international competition for the 2017/2018 European Business Award – Innovation. As a biopharmaceutical process developer and clinical manufacturer, Batavia Biosciences has been recognized to stand out with its unique innovative technologies and major contributions…


Batavia Biosciences teams up with international consortium to support polio eradication

Leiden, 16 January 2018 – Today Batavia Biosciences announces its partnership with an international consortium coordinated by PATH aiming to develop and manufacture safer novel oral poliovirus vaccines (nOPV). The project, funded by the Bill & Melinda Gates Foundation, has the potential to bolster efforts to sustain a polio-free world after the disease has been…


Menzo Havenga awarded CEO of the year 2017 the Netherlands

We are very proud that the prestigious organization “CEO Monthly” has awarded the title of “CEO of the Year 2017 – Netherlands” to our Chief Executive Officer, Menzo Havenga. Menzo was chosen on merit, and a clear vision and strategy. The selection of CEO of the Year is based on a combination of external votes…


We won FD Gazellen Award 2017!

Yesterday, Batavia Biosciences has been awarded with an FD Gazellen Award 2017 by the leading Dutch financial newspaper, Financieel Dagblad as one of the fastest growing mid-sized companies of the Netherlands. It is the third time we have won a FD Gazellen Award and we hope that many more will follow.


Batavia Biosciences increases its presence in France and rest of Europe

The commercial team is strengthened with the arrival of Oréda Boussadia, PhD, MBA. She has extensive experience in the therapeutic proteins field from the research to the clinic. See looks very much forward to meet with you and introduce Batavia Biosciences’ latest capabilities, technologies and innovation. Oréda will be present at: • European Antibody Congress in…


Batavia Biosciences teams up with international gene therapy consortium under Horizon2020 program

An international consortium, headed by the group of Prof. Dr. Frank Staal (Department of Immunohematology and Blood Transfusion, Leiden University Medical Centre) has been awarded a €6 million grant from the European Union to develop a gene therapy procedure for newborns suffering from severe combined immunodeficiency syndrome (SCID). According to Prof. Dr. Frank Staal, the development…


Wouter van Catz is Best Biopharmaceutical CFO

We congratulate our Director Finance, Wouter van Catz with being awarded Best Biopharmaceutical CFO of the Benelux in the Global CFO Excellence Awards 2017. These awards have been established to recognize CFO’s whose efforts give rise to the success of the firm. According to the voters of respected industry partners and CFO Monthly‘s own rigorous in-house…


Collaboration between Batavia Biosciences and UGA Biopharma

Both companies have the ambition to provide services and technologies supporting the development of high quality and affordable biopharmaceuticals. Through the partnership, two enzyme expressing monoclonal cell lines are now delivered. They were developed and validated by Batavia Biosciences using STEP® technology, and were guided by UGA Biopharma´s in-depth knowledge and experience in the development…


Novel plasmid technology at PEGS Boston

Our Director Operations, Marco Cacciuttolo, presented interesting new case studies for our STEP® Technology at the PEGS summit in Boston . For various ‘difficult to express proteins’ Batavia Biosciences was able to significantly increase product yields in CHO cells. Missed the presentation and interested in receiving more information? Please visit our booth or contact us at info@bataviabiosciences.com.